{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:19:59Z","timestamp":1794892799867,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ygyno.2024.01.006","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T18:32:18Z","timestamp":1706034738000},"page":"148-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Reviving peritoneal cytology: Exploring its role in endometrial cancer molecular classification"],"prefix":"10.1016","volume":"182","author":[{"given":"Anna-Sophie","family":"Villiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Zurbriggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Imboden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Solass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucine","family":"Christe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flurina A.M.","family":"Saner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gm\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman T.","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Siegenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2024.01.006_bb0005","doi-asserted-by":"crossref","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.006_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.006_bb0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2024.01.006_bb0020","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2019.01.011","article-title":"Incidence, patterns and prognosis of first distant recurrence after surgically treated early stage endometrial cancer: results from the multicentre FRANCOGYN study group","volume":"45","author":"Ouldamer","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.006_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ijgc-2019-000822","article-title":"Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment","volume":"30","author":"Legge","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"14","key":"10.1016\/j.ygyno.2024.01.006_bb0030","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/jnci\/88.14.980","article-title":"Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients","volume":"88","author":"Zuna","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.ygyno.2024.01.006_bb0035","first-page":"21","article-title":"The significance of positive peritoneal cytology in endometrial cancer","volume":"4","author":"Sutton","year":"1990","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.006_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"3","key":"10.1016\/j.ygyno.2024.01.006_bb0045","doi-asserted-by":"crossref","first-page":"329.e1","DOI":"10.1016\/j.ajog.2017.11.601","article-title":"Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database","volume":"218","author":"Seagle","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.ygyno.2024.01.006_bb0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jjco\/hyw063","article-title":"Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: a systematic review and meta-analysis","volume":"46","author":"Lee","year":"2016","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.006_bb0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2018.02.012","article-title":"Significance of abnormal peritoneal cytology on survival of women with stage I\u2013II endometrioid endometrial cancer","volume":"149","author":"Matsuo","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0060","article-title":"Prospective multicenter trial assessing the impact of positive peritoneal cytology conversion on oncological outcome in endometrial cancer patients undergoing minimally invasive surgery with the use of an intrauterine manipulator","author":"Siegenthaler","year":"2022","journal-title":"Ann. Surg. Oncol."},{"issue":"7471","key":"10.1016\/j.ygyno.2024.01.006_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.006_bb0070","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2024.01.006_bb0075","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.006_bb0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/his.14015","article-title":"Incorporation of molecular characteristics into endometrial cancer management","volume":"76","author":"Vermij","year":"2020","journal-title":"Histopathology."},{"issue":"2","key":"10.1016\/j.ygyno.2024.01.006_bb0085","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ygyno.2021.05.026","article-title":"Implementation of the 2021 molecular ESGO\/ESTRO\/ESP risk groups in endometrial cancer","volume":"162","author":"Imboden","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2024.01.006_bb0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/path.5034","article-title":"The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses","volume":"244","author":"McAlpine","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2022.02.024","article-title":"Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification","author":"Siegenthaler","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0100","series-title":"Female Genital Tumours: Medicine Series","article-title":"Female genital tumours: WHO classification of tumours","author":"WHO Classification of Tumours Editorial Board","year":"2020"},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.006_bb0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2024.01.006_bb0110","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0115","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","author":"Stelloo","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2023-004606","article-title":"Prognostic value of lymphovascular space invasion according to the molecular subgroups in endometrial cancer","author":"Siegenthaler","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.006_bb0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41379-020-0626-9","article-title":"Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups","volume":"34","author":"Rau","year":"2021","journal-title":"Mod. Pathol."},{"issue":"11","key":"10.1016\/j.ygyno.2024.01.006_bb0130","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1055\/a-0715-2964","article-title":"Interdisciplinary diagnosis, therapy and follow-up of patients with endometrial cancer. Guideline (S3-level, AWMF registry number 032\/034-OL, April 2018) - part 2 with recommendations on the therapy and follow-up of endometrial cancer, palliative care, ps","volume":"78","author":"Emons","year":"2018","journal-title":"Geburtshilfe Frauenheilkd."},{"issue":"7447","key":"10.1016\/j.ygyno.2024.01.006_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Network","year":"2013","journal-title":"Nature."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0140","article-title":"FIGO staging of endometrial cancer: 2023","author":"Berek","year":"2023","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.006_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2021.01.002","article-title":"Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study","volume":"161","author":"Kim","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2019.03.097","article-title":"Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer","author":"Reijnen","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.006_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2012.09.026","article-title":"Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer","volume":"128","author":"Garg","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0160","article-title":"Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer","author":"Kanno","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0165","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-021-09900-4","article-title":"Association between adjuvant therapy and survival in stage II\u2013III endometrial Cancer: influence of malignant peritoneal cytology","author":"Matsuo","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0170","doi-asserted-by":"crossref","DOI":"10.4103\/joc.joc_53_22","article-title":"Association of peritoneal cytology with other prognostic factors in endometrial cancer","author":"Maricic","year":"2022","journal-title":"J Cytol."},{"issue":"1","key":"10.1016\/j.ygyno.2024.01.006_bb0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygyno.2007.05.031","article-title":"Office hysteroscopy and the risk of microscopic extrauterine spread in endometrial cancer","volume":"107","author":"Taka\u010d","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.07.025","article-title":"Impact of uterine manipulator on oncological outcome in endometrial cancer surgery","author":"Padilla-Iserte","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"29","key":"10.1016\/j.ygyno.2024.01.006_bb0185","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Leon-Castillo","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2004.08.019","article-title":"Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium","author":"Creasman","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2024.01.006_bb0195","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1245\/s10434-016-5090-x","article-title":"Laparoscopic Indocyanine green sentinel lymph node mapping in endometrial Cancer","volume":"23","author":"Papadia","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2024.01.006_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjc.6602035","article-title":"Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis","author":"Tebeu","year":"2004","journal-title":"Br. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T18:57:35Z","timestamp":1719341855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":40,"alternative-id":["S0090825824000064"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reviving peritoneal cytology: Exploring its role in endometrial cancer molecular classification","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}